PTC
LLY icon

Philadelphia Trust Company’s Eli Lilly LLY Stock Holding History

Philadelphia Trust Company’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.55M Sell
3,859
-382
-9% -$387K 0.25% 65
2025
Q4 		$4.56M Sell
4,241
-20
-0.5% -$19.1K 0.31% 60
2025
Q3 		$3.25M Buy
4,261
+28
+0.7% +$20.8K 0.23% 69
2025
Q2 		$3.3M Sell
4,233
-2
-0% -$1.55K 0.25% 66
2025
Q1 		$3.5M Sell
4,235
-5
-0.1% -$4.16K 0.3% 66
2024
Q4 		$3.27M Sell
4,240
-34
-0.8% -$28.2K 0.24% 70
2024
Q3 		$3.79M Buy
4,274
+20
+0.5% +$18K 0.27% 68
2024
Q2 		$3.85M Buy
4,254
+10
+0.2% +$8K 0.3% 62
2024
Q1 		$3.3M Sell
4,244
-20
-0.5% -$14.2K 0.27% 68
2023
Q4 		$2.49M Buy
4,264
+34
+0.8% +$19.8K 0.23% 79
2023
Q3 		$2.27M Buy
4,230
+5
+0.1% +$2.58K 0.23% 82
2023
Q2 		$1.98M Sell
4,225
-315
-7% -$132K 0.19% 92
2023
Q1 		$1.56M Hold
4,540
– – 0.16% 100
2022
Q4 		$1.66M Sell
4,540
-210
-4% -$74.5K 0.18% 94
2022
Q3 		$1.54M Buy
4,750
+100
+2% +$31.7K 0.17% 88
2022
Q2 		$1.51M Sell
4,650
-1,020
-18% -$306K 0.15% 93
2022
Q1 		$1.62M Buy
5,670
+20
+0.4% +$5.15K 0.13% 100
2021
Q4 		$1.56M Sell
5,650
-500
-8% -$127K 0.11% 99
2021
Q3 		$1.42M Sell
6,150
-1,275
-17% -$315K 0.1% 111
2021
Q2 		$1.7M Hold
7,425
– – 0.12% 110
2021
Q1 		$1.39M Buy
7,425
+100
+1% +$19.6K 0.11% 114
2020
Q4 		$1.24M Sell
7,325
-75
-1% -$11.2K 0.1% 114
2020
Q3 		$1.09M Hold
7,400
– – 0.11% 106
2020
Q2 		$1.22M Hold
7,400
– – 0.13% 94
2020
Q1 		$1.03M Sell
7,400
-225
-3% -$30.9K 0.13% 85
2019
Q4 		$1M Sell
7,625
-1,200
-14% -$139K 0.09% 114
2019
Q3 		$987K Sell
8,825
-1,101
-11% -$123K 0.09% 118
2019
Q2 		$1.1M Sell
9,926
-250
-2% -$29.4K 0.1% 114
2019
Q1 		$1.32M Buy
10,176
+320
+3% +$38.9K 0.12% 98
2018
Q4 		$1.14M Buy
9,856
+100
+1% +$11.2K 0.12% 94
2018
Q3 		$1.05M Hold
9,756
– – 0.09% 117
2018
Q2 		$832K Hold
9,756
– – 0.07% 119
2018
Q1 		$755K Sell
9,756
-220
-2% -$17.7K 0.06% 128
2017
Q4 		$843K Buy
9,976
+125
+1% +$10.6K 0.07% 130
2017
Q3 		$843K Hold
9,851
– – 0.07% 127
2017
Q2 		$811K Buy
9,851
+200
+2% +$16.3K 0.07% 129
2017
Q1 		$812K Buy
9,651
+516
+6% +$41.3K 0.07% 130
2016
Q4 		$672K Buy
9,135
+2,235
+32% +$166K 0.05% 140
2016
Q3 		$554K Hold
6,900
– – 0.05% 143
2016
Q2 		$543K Hold
6,900
– – 0.05% 141
2016
Q1 		$497K Hold
6,900
– – 0.04% 131
2015
Q4 		$566K Hold
6,900
– – 0.05% 126
2015
Q3 		$577K Buy
6,900
+6,006
+672% +$507K 0.05% 117
2015
Q2 		$10.7K Sell
894
-10,014
-92% -$763K 0.04% 140
2015
Q1 		$793K Sell
10,908
-242
-2% -$17.2K 0.06% 120
2014
Q4 		$769K Sell
11,150
-15,620
-58% -$1.05M 0.06% 107
2014
Q3 		$1.74M Buy
26,770
+6,600
+33% +$418K 0.11% 85
2014
Q2 		$1.25M Buy
20,170
+100
+0.5% +$5.97K 0.08% 91
2014
Q1 		$1.18M Buy
20,070
+550
+3% +$30.7K 0.07% 99
2013
Q4 		$996K Sell
19,520
-25
-0.1% -$1.25K 0.06% 113
2013
Q3 		$984K Buy
19,545
+45
+0.2% +$2.36K 0.07% 109
2013
Q2 		$958K Buy
+19,500
New +$1.06M 0.07% 109

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Philadelphia Trust Company's LLY Position: Q1 2026 in Review

Philadelphia Trust Company reduced its Eli Lilly (LLY) stake by 9% in Q1 2026, selling an estimated $387K and leaving 3,859 shares worth $3.55M. The position accounts for 0.25% of the portfolio, ranked #65.

Philadelphia Trust Company first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.56M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Philadelphia Trust Company held 3,859 shares of Eli Lilly worth $3.55M as of Q1 2026.
  • Philadelphia Trust Company sold 382 Eli Lilly shares in Q1 2026, an estimated $387K.
  • Eli Lilly made up 0.25% of Philadelphia Trust Company's portfolio in Q1 2026, its #65 holding.
  • Philadelphia Trust Company first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Philadelphia Trust Company's Eli Lilly position peaked at $4.56M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Philadelphia Trust Company's 13F filing for Q1 2026, filed 13 May 2026.